1. Home
  2. AGIO vs HTZ Comparison

AGIO vs HTZ Comparison

Compare AGIO & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$34.45

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$6.55

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
HTZ
Founded
2007
1918
Country
United States
United States
Employees
N/A
26000
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AGIO
HTZ
Price
$34.45
$6.55
Analyst Decision
Buy
Hold
Analyst Count
8
4
Target Price
$39.88
$4.93
AVG Volume (30 Days)
969.5K
9.6M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$74.95
$5.00
Revenue Next Year
$165.77
$3.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$3.78
52 Week High
$46.00
$9.39

Technical Indicators

Market Signals
Indicator
AGIO
HTZ
Relative Strength Index (RSI) 66.34 67.50
Support Level $26.64 $4.94
Resistance Level $36.35 $7.35
Average True Range (ATR) 1.38 0.54
MACD 0.08 0.21
Stochastic Oscillator 71.17 77.45

Price Performance

Historical Comparison
AGIO
HTZ

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

Share on Social Networks: